The landscape of women’s preventive healthcare underwent significant updates and refinements in 2021, shaping the “coding” or framework for accessible and affordable care. Rooted in the Affordable Care Act (ACA), these guidelines ensure that most health insurance plans cover essential preventive services without cost-sharing, removing financial barriers to vital healthcare. This article delves into the key aspects of these updated guidelines, focusing on the advancements and changes implemented, particularly those effective from 2021 onwards and for plan years starting in 2026.
At the heart of this framework are the Health Resources and Services Administration (HRSA)-supported Women’s Preventive Services Guidelines. These guidelines, initially established in 2011 and critically reviewed and updated in 2021, are designed to improve women’s health across their lifespan. The updates are a result of continuous scientific advancements and identified gaps in clinical practice, ensuring the guidelines remain relevant and effective.
The process of updating these guidelines is rigorous. In 2016, HRSA initiated the Women’s Preventive Services Initiative (WPSI) with the American College of Obstetricians and Gynecologists (ACOG) to lead a comprehensive review. This initiative convened a coalition of experts to develop recommendations based on the model set by the National Academy of Medicine (NAM) for trustworthy clinical practice guidelines. A subsequent cooperative agreement awarded to ACOG in March 2021 ensured ongoing reviews and updates, at least every five years, or when new evidence emerges. This systematic review process can be considered the “coding” aspect – a structured, evidence-based approach to define and refine preventive healthcare standards.
Key Updates to Preventive Service Guidelines
The HRSA-supported guidelines encompass a range of preventive services tailored to women’s specific health needs. In December 2024, HRSA approved crucial updates to guidelines for:
-
Screening and Counseling for Intimate Partner and Domestic Violence: The updated guideline broadens the scope to recommend annual screening for intimate partner and domestic violence for both adolescent and adult women. It emphasizes providing or referring to intervention services when needed, encompassing physical, sexual violence, stalking, psychological aggression, reproductive coercion, neglect, and threats. Intervention services include counseling, education, harm reduction, and referrals to support services. This update reinforces the importance of routinely addressing interpersonal violence as a critical preventive health measure.
-
Breast Cancer Screening for Women at Average Risk: The revised guidelines for breast cancer screening maintain the recommendation for average-risk women to initiate mammography screening between 40 and 50 years, continuing at least biennially, and as frequently as annually until at least age 74. A significant update clarifies that if additional imaging (MRI, ultrasound, mammography) or pathology evaluation is needed to complete screening or address findings, these services are also recommended as part of the preventive screening process. This ensures comprehensive coverage for necessary follow-up diagnostics.
New Preventive Service Guideline
A notable addition to the guidelines is a new recommendation for:
- Patient Navigation Services for Breast and Cervical Cancer Screening: Recognizing that access to screening is not just about availability but also about navigability, the WPSI now recommends patient navigation services for breast and cervical cancer screening and follow-up. These services are person-centered, involving direct contact to assess and address individual patient needs. Components include personalized assessment and planning, healthcare system navigation, referrals for support services (like translation, transportation, social services), and patient education. This new guideline addresses healthcare access disparities and aims to improve screening utilization through personalized support.
Current Preventive Service Guidelines
Beyond the updated and new guidelines, a comprehensive suite of preventive services remains crucial under the HRSA guidelines. These “current guidelines” represent the ongoing “code” for preventive care, including:
-
Screening for Anxiety: Recommends anxiety screening for adolescent and adult women, including pregnant and postpartum individuals. Frequency is based on clinical judgment, emphasizing screening for those not recently assessed due to the high prevalence and impact of untreated anxiety.
-
Screening for Cervical Cancer: Recommends cervical cancer screening for women aged 21 to 65. For women 21-29, cytology (Pap test) every 3 years is recommended. For women 30-65, cytology and HPV testing every 5 years or cytology alone every 3 years are options. Over-screening in average-risk women is discouraged.
-
Obesity Prevention in Midlife Women: Counseling for midlife women (40-60 years) with normal or overweight BMI (18.5-29.9 kg/m2) to maintain or limit weight gain is recommended. Counseling includes discussions on healthy eating and physical activity.
-
Breastfeeding Services and Supplies: Comprehensive lactation support services, including consultation, counseling, education, peer support, and breastfeeding equipment (like double electric breast pumps), are recommended during antenatal, perinatal, and postpartum periods to promote successful breastfeeding.
-
Contraception: Access to the full range of FDA-approved contraceptives and contraceptive care is recommended for adolescent and adult women to prevent unintended pregnancies and improve birth outcomes. This includes screening, education, counseling, provision of contraceptives, and follow-up care.
-
Counseling for Sexually Transmitted Infections (STIs): Directed behavioral counseling for sexually active adolescent and adult women at increased STI risk is recommended. Risk assessment is crucial, with counseling to reduce STI risk considered even for those not identified as high risk.
-
Human Immunodeficiency Virus Infection (HIV): At least one lifetime HIV screening test is recommended for all adolescent and adult women (ages 15+). Risk-based screening should begin at age 13, with annual or more frequent rescreening for high-risk individuals. Universal screening for pregnant women is also recommended.
-
Well-Woman Preventive Visits: At least one annual preventive care visit is recommended from adolescence onwards to ensure delivery of all age and risk-appropriate preventive services, including preconception, prenatal, and interconception care.
-
Screening for Diabetes in Pregnancy: Screening for gestational diabetes mellitus (GDM) after 24 weeks of gestation is recommended for pregnant women to prevent adverse birth outcomes. Early screening is recommended for those with type 2 diabetes or GDM risk factors.
-
Screening for Diabetes after Pregnancy: Screening for type 2 diabetes is recommended for women with a history of GDM, ideally within the first year postpartum, and at least every 3 years for a minimum of 10 years post-pregnancy.
-
Screening for Urinary Incontinence: Annual screening for urinary incontinence is recommended to assess its presence and impact on activities and quality of life, facilitating further evaluation and treatment if needed.
Implementation and Access
These updated and current guidelines, representing the “Coding For Preventive Care 2021” framework, are crucial for ensuring women receive necessary preventive healthcare without financial burden. Non-grandfathered health plans are mandated to provide coverage without cost-sharing, aligning with these guidelines. While the 2021 updates have implications for plan years starting in 2026, plans are generally expected to adhere to the previously updated guidelines in the interim.
The Women’s Preventive Services Initiative also provides implementation considerations to aid in translating these guidelines into clinical practice, further enhancing the practical application of this “coding” system for preventive care.
For further inquiries regarding these guidelines and their implementation, contact [email protected].
